Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Wei-U Belladonna Aluminum Capsules is a combination pharmaceutical product developed by Sichuan Good Doctor Panxi Pharmaceutical for the treatment of various gastric conditions. The formulation typically contains three active ingredients: aluminum hydroxide, vitamin U (methylmethionine sulfonium chloride), and belladonna fluid extract. Aluminum hydroxide serves as an antacid that neutralizes gastric acid and provides a protective layer over ulcerated surfaces. Vitamin U promotes the regeneration of the gastric mucosa and the development of granulation tissue, aiding in the healing of ulcers. Belladonna fluid extract contains alkaloids that exert anticholinergic effects, inhibiting glandular secretion and relieving pain caused by smooth muscle spasms. The drug is primarily indicated for the relief of heartburn, acid reflux, and gastric pain associated with hyperacidity and chronic gastritis.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Wei-U Belladonna Aluminum Capsules.